Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-19

Clinical Trial Update: Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial [Phase 4]

View source ↗

Summary

The SMART Phase 4 trial of Sanctura (trospium chloride) assessing pharmacokinetics in elderly participants has completed, with results posted. Sponsored by Alle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sanctura (trospium chloride)

Snippet

Sponsor: Allergan | Conditions: Elderly, Pharmacokinetics | Phase 4 | Status: COMPLETED | Results posted: 2011-12-19